DGAP-News: CureVac Announces Full Exercise of Underwriters' Option to Purchase Additional Common Shares
Examples include discussion of the potential efficacy of the Company's vaccine candidate and the Company's strategies, financing plans, growth opportunities and market growth.
- Examples include discussion of the potential efficacy of the Company's vaccine candidate and the Company's strategies, financing plans, growth opportunities and market growth.
- Forward looking statements are based on management's current beliefs and assumptions and on information currently available to the Company.
- However, these forward-looking statements are not a guarantee of the Company's performance, and you should not place undue reliance on such statements.
- For further information, please reference the Company's reports and documents filed with the U.S. Securities and Exchange Commission (SEC).